Related Experiment Video
Updated: Jan 25, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
SMARCA4-Deficient Undifferentiated Thoracic Tumor: Clinical Features and Prognosis of a Case Series and Literature
Fangzhen Shan1, Shuntao Liang2, Youwen Zhang3
1Medical Research Center, Affiliated Hospital of Jining Medical University, Shandong, China.
Introduction:
Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) are rare and aggressive epithelioid neoplasms characterized by the loss of the SMARCA4 gene. These tumors are typically diagnosed at advanced stages and exhibit a dismal prognosis. Currently, there are no standardized treatment protocols or approved targeted therapies.
Methods:
We present a case series of nine patients diagnosed of thoracic SMARCA4-UT, detailing demographic, pathological, imaging, and treatment data. Moreover, a comprehensive literature review and genomic analysis of SMARCA4 mutations in lung cancer were also performed.
Results:
The cohort comprised predominantly male smokers (mean age: 63.0 ± 9.6 years). All cases exhibited loss of BRG1 expression, with negative staining for TTF-1 and p40, while SMARCB1/INI-1 expression was preserved. Patients showed poor responses to conventional chemotherapy but demonstrated partial responsiveness to immunotherapy or targeted agents. Genomic analysis of SMARCA4 mutations in lung cancer demonstrates that SMARCA4 mutations, primarily located in the SNF2-related and helicase conserved C-terminal domains, are associated with a poorer prognosis in lung cancer.
Conclusion:
Immunotherapy and targeted therapies show promise in managing thoracic SMARCA4-UT, warranting further investigation. Further exploring the genetic and molecular landscape of this tumor might reveal potential therapeutic targets.
Insights
Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) are aggressive neoplasms. Immunotherapy and targeted agents show promise for managing SMARCA4-UT, suggesting new therapeutic avenues.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) are rare, aggressive epithelioid neoplasms.
- These tumors are characterized by SMARCA4 gene loss and typically diagnosed at advanced stages with poor prognosis.
- Current treatment lacks standardized protocols and approved targeted therapies.
Purpose of the Study:
- To present a case series of nine patients with thoracic SMARCA4-UT.
- To detail demographic, pathological, imaging, and treatment data for these patients.
- To conduct a literature review and genomic analysis of SMARCA4 mutations in lung cancer.
Main Methods:
- Case series of nine patients with thoracic SMARCA4-UT.
- Comprehensive literature review.
- Genomic analysis of SMARCA4 mutations in lung cancer.
Main Results:
- The cohort consisted of predominantly male smokers (mean age 63 years).
- All cases showed loss of BRG1 expression, negative for TTF-1 and p40, with preserved SMARCB1/INI-1.
- Patients responded poorly to chemotherapy but showed partial response to immunotherapy or targeted agents. SMARCA4 mutations are linked to poorer lung cancer prognosis.
Conclusions:
- Immunotherapy and targeted therapies demonstrate potential for managing thoracic SMARCA4-UT.
- Further investigation into these treatment modalities is warranted.
- Exploring the tumor's genetic and molecular landscape may reveal novel therapeutic targets.
More Related Videos
06:57Transaxillary First Rib Resection for Treatment of the Thoracic Outlet Syndrome
Published on: September 13, 2020
04:33Spinal Hernia Repair and Cauda Equina Repositioning After Lumbar Decompression under Three-Dimensional Microscopy: A Case Report and Literature Review
Published on: November 8, 2024
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Myocarditis II: Clinical Features and Diagnostic Tests